More recently, ONX-0914 has been shown to be effective in pediatric T-ALL cases with t (4; 11) (q21; q23) chromosomal translocation that leads to the expression of MLL–AF4 fusion protein conferring poor outcome [50]. Here, KMT2A is linked to acute lymphoblastic leukemia.